<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR24">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Monteil</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Kwon</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Prado</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Hagelkruys</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Wimmer</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Stahl</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Leopoldi</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Garreta</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Pozo</surname>
    <given-names>CH</given-names>
   </name>
   <name>
    <surname>Prosper</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Romero</surname>
    <given-names>JP</given-names>
   </name>
   <name>
    <surname>Wirnsberger</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Slutsky</surname>
    <given-names>AS</given-names>
   </name>
  </person-group>
  <article-title>Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2</article-title>
  <source>Cell</source>
  <year>2020</year>
  <volume>181</volume>
  <issue>4</issue>
  <fpage>905</fpage>
  <lpage>913.e7</lpage>
  <?supplied-pmid 32333836?>
  <pub-id pub-id-type="pmid">32333836</pub-id>
 </element-citation>
</ref>
